Elsevier

Brain Research

Volume 417, Issue 1, 4 August 1987, Pages 51-58
Brain Research

Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens

https://doi.org/10.1016/0006-8993(87)90178-8Get rights and content

Abstract

Several recent reports have demonstrated that opiate action in both the ventral tegmental area (VTA) and the nucleus accumbens (N.Acc.) produces an increase in locomotor activity. In the present experiments, the effect of repeated bilateral injections into these sites of either morphine or the mu opioid receptor agonist Tyr-d-Ala-Gly-NMe-Phe-Gly-ol (DAGO) was investigated. As previously reported with morphine and other opioids, repeated injections of either morphine or DAGO into the VTA produced a progressive enhancement or sensitization of their locomotor activating effects. On the other hand, although both substances injected into the N.Acc. elicited increased locomotion, repeated injections did not lead to sensitization. It has been suggested that the increased locomotor activity produced by opiate injection into the VTA is dopamine-dependent while that produced by intra-N.Acc. injections is not15. The present findings provide neuroanatomical support for the view thatsensitization to the locomotor activating effects of opiates and opioids brought about by repeated drug exposure involves the mesolimbic dopamine system.

Reference (34)

  • SchnurP. et al.

    Effects of naloxone on morphine-induced sedation and hyperactivity in the hamster

    Pharmacol. Biochem. Behav.

    (1986)
  • VezinaP. et al.

    Conditioning and place-specific sensitization of increases in activity indued by morphine in the VTA

    Pharmacol. Biochem. Behav.

    (1984)
  • WamsleyJ.K. et al.

    Immunohistochemical localization of enkephalin in rat forebrain

    Brain Research

    (1980)
  • BabbiniM. et al.

    Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment

    Br. J. Pharmacol.

    (1972)
  • BroekkampC.L.E. et al.

    Stimulant effects of enkephalin injection into the dopaminergic A10 areas

    Nature (London)

    (1979)
  • BunneyW.C. et al.

    Chronic morphine-induced hyperactivity in rats is altered by nucleus accumbens and ventral tegmental lesions

    Psychopharmacology

    (1984)
  • CreeseI.

    Stimulants: Neurochemical, Behavioral and Clinical Perspectives

    (1983)
  • Cited by (145)

    • Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians

      2018, Neuroscience
      Citation Excerpt :

      Consistent with a previous report testing effects of DAMGO and the opioid antagonist naloxone (Passarelli et al., 1999) in planarians, neither DAMGO nor NTX caused stereotyped motor behaviors such as C-shapes or screw-like hyperkinesias. DAMGO, as well as the closely related analog DAGO, consistently produce locomotor activation following acute exposure in mice (Mickley et al., 1990; Michael-Titus et al., 1989) and rats (Locke and Holtzman, 1986; Vezina et al., 1987; Shim et al., 2014). Morphine, in contrast, produces complex effects on locomotor activity in rodents that are species- and dose-dependent, as well as bimodal in some cases, with low doses that are more selective for mu opioid receptors often enhancing locomotor activation and higher doses that also activate kappa and delta opioid receptors reducing locomotor activity (Brady and Holtzman, 1981; Murphy et al., 2001).

    • Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse

      2014, Neuroscience
      Citation Excerpt :

      The process of sensitization has been well characterized in the context of psychomotor stimulants (Dougherty and Ellinwood, 1981), and is also observed with opiates (Babbini et al., 1975; Kornetsky, 2004). The VTA is required for the induction of behavioral sensitization to both opiates and psychomotor stimulants (Joyce and Iversen, 1979; Vezina et al., 1987; Vezina and Stewart, 1990). Chronic BDNF infusions into the NAc or VTA enhance the initial psychomotor effects of cocaine, facilitate the development of cocaine-induced sensitization and induce long-lasting increases in reinforcing efficacy that can be observed more than one month after the cessation of BDNF infusions (Table 2; Horger et al., 1999).

    View all citing articles on Scopus
    View full text